Overview of model-assisted design for phase I dose-finding trials in oncology-Reference-Cited by-同舟云学术

Overview of model-assisted design for phase I dose-finding trials in oncology

Published:2022 Issue:1 Volume:43 Page:3-36
ISSN:0918-4430
Container-title:Japanese Journal of Biometrics
language:en
Short-container-title:Jpn J Biomet

Author:

Hashizume Koichi¹,Takeda Kentaro²,Sato Hiroyuki³,Hirakawa Akihiro³,Sozu Takashi⁴

Affiliation:

1. Department of Information and Computer Technology, Graduate School of Engineering, Tokyo University of Science

2. Department of Data Science, Astellas Pharma Global Development, Inc.

3. Department of Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University

4. Department of Information and Computer Technology, Faculty of Engineering, Tokyo University of Science

Publisher

The Biometric Society of Japan

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jjb/43/1/43_3/_pdf

Reference78 articles.

1. Araujo, D. V., Oliva, M., Li, K., Fazelzad, R., Liu, Z. A., and Siu, L. L. (2021). Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era. European Journal of Cancer 158, 85-98.

2. Barlow, R. E., Bartholomew, D. J., Bremner, J. M., and Brunk, H. D. (1972). Statistical Inference Under Order Restrictions: The Theory and Application of Isotonic Regression. Third Edition. New York: John Wiley & Sons.

3. Barnett, H. Y., George, M., Skanji, D., Saint-Hilary, G., Jaki, T., and Mozgunov, P. (2021). A comparison of model-free phase I dose escalation designs for dual-agent combination thera-pies. [Preprint] available at https://doi.org/10.48550/arXiv.2104.14923. (Accessed 19 August 2022).

4. Bekele, B. N. and Thall, P. F. (2004). Dose-finding based on multiple toxicities in a soft tissue sarcoma trial. Journal of the American Statistical Association 99, 26-35.

5. Brahmer, J. R., Drake, C. G., Wollner, I., Powderly, J. D., Picus, J., Sharfman, W. H., Stanke- vich, E., Pons, A., Salay, T. M., McMiller, T. L., Gilson, M. M., Wang, C., Selby, M., Taube, J. M., Anders, R., Chen, L., Korman, A. J., Pardoll, D. M., Lowy, I., and Topalian, S. L. (2010). Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: Safety, clinical activity, pharmacodynamics, and immunologic correlates. Journal of Clinical Oncology 28, 3167-3175.